Product Details for NDA 202008
AMYVID (FLORBETAPIR F-18)
10-50ML (13.5-51mCi/ML)
Marketing Status: Prescription
10-100ML (13.5-51mCi/ML)
Marketing Status: Prescription
10-30ML (13.5-51mCi/ML)
Marketing Status: Discontinued
10ML (13.5-51mCi/ML)
Marketing Status: Discontinued
10-50ML (13.5-51mCi/ML)
Marketing Status: Prescription
Active Ingredient: FLORBETAPIR F-18
Proprietary Name: AMYVID
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10-50ML (13.5-51mCi/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N202008
Product Number: 003
Approval Date: Apr 6, 2012
Applicant Holder Full Name: AVID RADIOPHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
AMYVID (FLORBETAPIR F-18)
Proprietary Name: AMYVID
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10-50ML (13.5-51mCi/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N202008
Product Number: 003
Approval Date: Apr 6, 2012
Applicant Holder Full Name: AVID RADIOPHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
10-100ML (13.5-51mCi/ML)
Marketing Status: Prescription
Active Ingredient: FLORBETAPIR F-18
Proprietary Name: AMYVID
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10-100ML (13.5-51mCi/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N202008
Product Number: 004
Approval Date: Oct 13, 2023
Applicant Holder Full Name: AVID RADIOPHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
AMYVID (FLORBETAPIR F-18)
Proprietary Name: AMYVID
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10-100ML (13.5-51mCi/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N202008
Product Number: 004
Approval Date: Oct 13, 2023
Applicant Holder Full Name: AVID RADIOPHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
10-30ML (13.5-51mCi/ML)
Marketing Status: Discontinued
Active Ingredient: FLORBETAPIR F-18
Proprietary Name: AMYVID
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10-30ML (13.5-51mCi/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N202008
Product Number: 002
Approval Date: Apr 6, 2012
Applicant Holder Full Name: AVID RADIOPHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
AMYVID (FLORBETAPIR F-18)
Proprietary Name: AMYVID
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10-30ML (13.5-51mCi/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N202008
Product Number: 002
Approval Date: Apr 6, 2012
Applicant Holder Full Name: AVID RADIOPHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
10ML (13.5-51mCi/ML)
Marketing Status: Discontinued
Active Ingredient: FLORBETAPIR F-18
Proprietary Name: AMYVID
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10ML (13.5-51mCi/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N202008
Product Number: 001
Approval Date: Apr 6, 2012
Applicant Holder Full Name: AVID RADIOPHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: AMYVID
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10ML (13.5-51mCi/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N202008
Product Number: 001
Approval Date: Apr 6, 2012
Applicant Holder Full Name: AVID RADIOPHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information